CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
Motus Cleansing System (MCS)device
Likely dose
Not stated in record
Key inclusion· 4
  • Age 18-75 years inclusive
  • BMI 18.5-35 inclusive
  • Candidate for diagnostic, screening, or surveillance colonoscopy
  • Signed informed consent
Key exclusion· 9
  • Known inflammatory bowel disease
  • Known diverticulitis or prior incomplete colonoscopy due to diverticular disease
  • Known or detected bowel obstruction
  • Prior surgery to colon and/or rectum

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03026075
NCT03026075N/ACompleted

Evaluation of the Performance of the Motus Cleansing System

Motus GI Medical Technologies Ltd·interventional·Posted Jan 20, 2017·Updated Feb 11, 2019

In Brief

A clinical study evaluating Motus Cleansing System (MCS) for CRC. Completed, enrolled 47 participants across 3 sites in 2 countries.

Detailed Summary

The study is multi-center study ,planned as a single arm, open trial, aimed at evaluating the performance and safety of a colon cleansing device during a colonoscopy procedure in a poorly prepared colons.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCRC
CountriesGermany, Netherlands
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 20, 2017
Enrollment StartDec 22, 2016
Primary CompletionMay 31, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.5 years ago

Interventions

Motus Cleansing System (MCS)device

The MCS enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.